TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
47 hedge funds and large institutions have $70.2M invested in Talis Biomedical Corporation Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.
Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
11
Reduced
16
Closed
5
Calls
$84K
Puts
$74K
Net Calls
+$10K
Net Calls Change
-$1.78M
Top Buyers
| 1 |
GC
1
Greenlight Capital
New York
|
$6.29M |
| 2 |
PCM
2
Prelude Capital Management
New York
|
$755K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.91M |
| 4 |
4
Two Sigma Investments
New York
|
$315K |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$30.6M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | – | – | – |
|
|
CAC
52
Cowen and Company
New York
| – | – | – | – |
|
|
CFGS
53
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
EI
54
Ellevest Inc
New York
| $0 | 3 | +3 | New |
|